However, the differential impact of HLA-C∗06:02 on PsA and PsC risk disappeared after we conditioned on HLA-B amino acid position 45 (p = 0.12), suggesting that this reduced effect was the result of linkage to HLA-B. The gene discussed is HLA-B; the disease is pancreatic serous cystadenoma.